Search Results

1 - 10 of 39 items :

  • nuclear program x
  • Internal Medicine x
Clear All
The development of nuclear medicine in Slovenia and Ljubljana; half a century of nuclear medicine in Slovenia

. Kocijančič A, Mrevlje F.(ed.). Interna medicina . (Internal medicine), Ljubljana: EWO, DZS; 1993. 1145 pages. Avsec Letonja D, Vončina J. Transplantacijska dejavnost: donorski program. 1, Organi . (Transplant activity - a donor programme). Ljubljana: Zavod RS za presaditev organov in tkiv Slovenija-transplant; 2003. 146 pages. Hodolic M. Role of (18)F-choline PET/CT in evaluation of patients with prostate carcinoma. Radiol Oncol 2011; 45 : 17-21.

Open access
Transcription factors gene expression in chronic rhinosinusitis with and without nasal polyps

.ppat.1004671 25803478 van Meijgaarden KE Haks MC Caccamo N Dieli F Ottenhoff THM Joosten SA Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset PLoS Pathog 2015 11 e1004671 10.1371/journal.ppat.1004671 40 Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T

Open access
Gonadotoxicity Evaluation of Oral Administration of Zidolam in Male Albino Rats

References Report on the Global HIV/AIDS Epidemic. UNAIDS: Joint United Nations Programme on HIV/AIDS, 2000. Fauci JV. Editorial: Twenty five years of HIV/AIDS. Science. 2006; pp: 313-409. World Health Organization. World's AIDS and Tuberculosis Situation. Tuberculosis Department, WHO, Geneva, 2005. Palella Jr. FA, Delany KM, Moorman AC. Declining morbidity and mortality among patients with advanced HIV infection. N Engl J Med. 1998

Open access
Prognostic significance of plasma osteopontin level in breast cancer patients

References [1] Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1. 2, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10. Lyon, France: International Agency for Research on Cancer [available from], <http:// asp>; 2010 [accessed on 24.09.2012]. [2] The National Cancer Registry Program of Egypt (NCRPE). Reports and Statistics: Aswan, Damietta & El-Minia [available from], <http://www.> [accessed 5

Open access
Circulating oxidized low density lipoprotein and non-high density lipoprotein cholesterol concentrations in metabolic syndrome Egyptian women before and after specific nutritional therapy

report of National cholesterol Education program (NCEP) Expert Panel on Detection, Evaluations, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation. 2002; 106: 3143-3221. 8. Wagner AM,Perez A, Zapico E, Ordonezuanos J. Non-H DL cholesterol and apolipoprotein B in the dyslipidemic classification of type 2 diabetic patients. Diabetes Care. 2003; 26: 2048-2051. 9. Pischon T, Girman GJ, Sacks FM, Rifai N, Stampfer NJ, Rimm EB. Non -high density lipoprotein cholesterol and Apolipoprotein B

Open access
Metabolic syndrome and Cancer: Do they share common molecular pathways?

these trials and possible co-existence of confounding or discriminatory factors should be taken into account. Furthermore, as indicated in Table 1 , a universally accepted definition of the metabolic syndrome is missing and different criteria have been adopted by several groups [ 8 – 10 ]. Table 1 Definitions of the Metabolic Syndrome Risk Factors National Cholesterol Education Program’s Adult Treatment Panel III (ATP III) (8) ≥ 3 of 5 criteria necessary WHO 1999 (9) Impaired glucose regulation or hyperinsulinemia and ≥ 2 of criteria necessary

Open access
Targeting Bruton Tyrosine Kinase: A novel strategy in the treatment of B-cell lymphomas

domain. PIP 3 : Phosphatidylinositol 3,4,5-triphosphate. PKC: Protein kinase C. Lyn, Syk: Src-family tyrosine kinases. BLNK: B-cell linker protein. PLCγ2: Phospholipase C γ-2. NF-κB: Nuclear factor kappa B. Btk contains five domains through which it interacts with other proteins of the B-cell receptor signalling pathway, leading to PLCγ2 and eventually, NF-κB activation. PH is used for binding to PIP 3 , which recruits Btk to the plasma membrane; TH contains a zinc-finger motif; SH2 is used for docking to phosphorylated tyrosine residues on other proteins, allowing

Open access
Functional And Survival Outcome Of Egyptian Children And Adolescents With Malignant Bone Tumors: An Experience In A Setting Of Limited Health Resource

poor responders’ osteosarcoma including immunomodulation. Improvements in clinical outcomes may largely been attributable to a multidisciplinary team-based approach consequently at 2014, a multidisciplinary teamwork (paediatrician, orthopaedic surgeon, and nuclear medicine physician) evolved and finally succeeded in establishment of a weekly multidisciplinary solid tumour clinic at Paediatric haematology/ oncology clinic to improve the management and outcome of paediatric bone tumour through better communication and rapid decisions. Furthermore in the developing

Open access
25th Hellenic conference of Clinical Oncology

’S BELIEFS AND ATTITUDES IN THE PREFECTURE OF SERRES TOWARDS BREAST CANCER SCREENING USING THE HEALTH BELIEF MODEL Tragouda S. 1 , Trigoni M. 2 , Paraskeuopoulou S. 3 1 . Post-graduate student of the Healthcare Management post-graduate studies program (Hellenic Open University) 2 . Head of Department of Social Services University Hospital of Crete, Consultant Professor of Hellenic Open University, Greece 3 . Consultant Professor of Hellenic Open University, Greece Introduction : Breast cancer is the most common form of neoplasm in women and the most frequently

Open access
Immunohistochemical Aspects of Cell Death in Diabetic Nephropathy

:// 4. BATUMAN V, SOMAN A, SCHMIDT R, SOMAN S. Diabetic Nephropathy. [cited 07.05.2015] Available from: 5. ADA, Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes. 2015; 33(2): 97-111. 6. HOTCHKISS RS, STRASSER A, McDUNN JE, SWANSON PE. Cell death. N Engl J Med. 2009; 361(16): 1570-83. 7. ELMORE S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007; 35(4): 495-516. 8

Open access